LD Logo.png
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
04 oct. 2023 10h08 HE | Lowey Dannenberg, P.C.
NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty claim...
LD Logo.png
Lowey Dannenberg, P.C. is Investigating Illumina, Inc. (NASDAQ: ILMN) for Potential Breaches of Fiduciary Duty by Its Board of Directors
29 sept. 2023 14h45 HE | Lowey Dannenberg, P.C.
NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Lowey Dannenberg P.C., a preeminent law firm in obtaining redress for consumers and investors, is investigating a potential breach of fiduciary duty...
logo-alt.png
Pharmacogenomics Market is estimated to be US$ 33.10 million by 2030 with a CAGR of 4.50% during the forecast period - By PMI
14 mars 2023 08h35 HE | PMI
Covina, March 14, 2023 (GLOBE NEWSWIRE) -- Pharmacogenomics Market accounted for US$ 6753.66 million in 2020 and is estimated to be US$ 15796.9 million by 2030 and is anticipated to register a CAGR...
AMR Logo.png
Solid Tumor Testing Market to Grow $46.7 Billion by 2031: Allied Market Research
09 nov. 2022 02h43 HE | Allied Market Research
Portland, OR, Nov. 09, 2022 (GLOBE NEWSWIRE) -- A new business intelligence report released by Allied Market Research, the global Solid Tumor Testing Market garnered $23.8 billion in 2021, and is...
logo-alt.png
Global Lung Cancer Diagnostic Test Market is estimated to be US$ 4.07 billion by 2030 with a CAGR of 7.50% during the forecast period - By PMI
19 avr. 2022 09h52 HE | PMI
Covina, April 19, 2022 (GLOBE NEWSWIRE) -- Lung cancer starts in the lungs and can spread to the lymph nodes or other body organs, including the brain. Cancer that has progressed to other organs can...
logo-alt.png
Global Bioinformatics Platform Market is estimated to be US$ 14.0 Billion by 2029 with a CAGR of 14.7% during the Forecast Period - PMI
15 juin 2020 11h35 HE | PMI
Covina, CA, June 15, 2020 (GLOBE NEWSWIRE) -- The global bioinformatics platform market accounted for US$ 3.6 billion in 2019 and is estimated to be US$ 14.0 billion by 2029 and is anticipated to...
LOGO-01.png
Burning Rock deepens cooperation with Illumina to promote development and standardization of NGS-based cancer therapy selection in China
10 mai 2020 20h00 HE | Burning Rock Biotech Limited
SHANGHAI, China, May 10, 2020 (GLOBE NEWSWIRE) -- Burning Rock and Illumina (NASDAQ: ILMN), a global leader in gene sequencing and array-based technologies, jointly announced today that they are...
Shareholders Foundation
Update: Lawsuit for Investors in NASDAQ: ILMN shares against Illumina, Inc. announced by Shareholders Foundation
12 juin 2018 09h10 HE | Shareholders Foundation, Inc.
SAN DIEGO, June 12, 2018 (GLOBE NEWSWIRE) -- The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in shares of Illumina, Inc. (NASDAQ:ILMN).  Investors, who...
real.jpg
Harvard Pilgrim and Illumina sign first-of-its-kind value-based contract
20 févr. 2018 10h00 HE | Real Endpoints
SAN DIEGO, WELLESLEY, Mass. and WESTPORT, Conn., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Illumina, Inc. and Harvard Pilgrim Health Care announced on February 1 a major new value-based contract (VBC) – one...
ILMN LOSS ALERT: Rosen Law Firm Reminds Illumina, Inc. Investors of Important Deadline in Class Action – ILMN
24 janv. 2017 20h35 HE | The Rosen Law Firm PA
NEW YORK, Jan. 24, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Illumina, Inc. securities (NASDAQ:ILMN) from July 26, 2016 through October 10,...